Overview

A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-04-21
Target enrollment:
Participant gender:
Summary
The aim of this trial is to evaluate the efficacy and safety of HRS-7535 compared with placebo in subjects with type 2 diabetes mellitus with inadequate glycemic control with diet and exercise
Phase:
PHASE3
Details
Lead Sponsor:
Shandong Suncadia Medicine Co., Ltd.